Other OTC Pharmaceuticals - Kuwait

  • Kuwait
  • In Kuwait, the revenue generated in the market Other OTC Pharmaceuticals amounts to US$98.76m in 2024.
  • It is projected that this market will experience an annual growth rate of 1.16% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this sector, with US$7,171.00m in 2024.
  • In terms of per capita revenue, in 2024, each person in Kuwait generates US$22.71.
  • Kuwait's Other OTC Pharmaceuticals market is experiencing a surge in demand for herbal remedies and traditional medicines.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Kuwait is experiencing steady growth due to various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Kuwait play a significant role in driving the growth of the Other OTC Pharmaceuticals market. Kuwaiti consumers have shown a growing interest in self-medication and taking care of their health and well-being. This preference can be attributed to the increasing awareness about the benefits of OTC medications and the convenience they offer. Additionally, customers in Kuwait have a strong preference for products that are easily accessible, affordable, and do not require a prescription. This has led to a surge in demand for over-the-counter pharmaceuticals in the country.Trends in the market further contribute to the growth of the Other OTC Pharmaceuticals market in Kuwait. One notable trend is the rising popularity of natural and herbal remedies. Kuwaiti consumers are increasingly seeking alternative and holistic approaches to healthcare, which has led to an increased demand for OTC products derived from natural ingredients. This trend is in line with the global shift towards natural and organic products, and pharmaceutical companies are capitalizing on this by introducing a wide range of natural OTC medications in the market.Local special circumstances also play a role in the development of the Other OTC Pharmaceuticals market in Kuwait. The country has a well-established healthcare system that provides accessible and affordable healthcare services to its citizens. However, there is a growing burden on the healthcare system due to the increasing population and the rising prevalence of chronic diseases. As a result, the government and healthcare providers are encouraging self-care and self-medication to alleviate the pressure on the healthcare system. This has created a favorable environment for the growth of the Other OTC Pharmaceuticals market in Kuwait.Underlying macroeconomic factors also contribute to the growth of the Other OTC Pharmaceuticals market in Kuwait. The country has a high per capita income and a strong economy, which enables consumers to afford OTC medications. Additionally, Kuwait has a young and growing population, which creates a larger consumer base for OTC pharmaceutical products. The government's focus on healthcare and well-being further supports the growth of the market.In conclusion, the Other OTC Pharmaceuticals market in Kuwait is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing interest in self-medication, the popularity of natural and herbal remedies, the encouragement of self-care by the healthcare system, and the favorable macroeconomic environment all contribute to the development of the market in Kuwait.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)